Industry Research Reports

Home > Reports > Consumer Goods > HMO Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

HMO Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Consumer Goods

Published Date: 2025-03-10

Pages: 100 Pages

Report ld: 3570295

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

HMO Formula Market Size(US$)

CAGR 2025-2031

11%

Market Size,2031

USD 7,856

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 4,200 million

Market Forecast in 2031(Value)

US$ 7,856 million

CAGR

11%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for HMO Formula was estimated to be worth US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.

HMO (Human Milk Oligosaccharides) formula milk refers to a specialized type of infant formula that incorporates oligosaccharides found naturally in human breast milk. These oligosaccharides are complex carbohydrates that serve various beneficial purposes, particularly for the infant’s digestive system and immune health. Breast milk is known to contain more than 200 different types of oligosaccharides, which play an important role in the development of the infant's gut microbiota, immunity, and overall health. Since these oligosaccharides are difficult to replicate, HMO formula has emerged as a substitute that mimics the benefits of breast milk, offering an advanced alternative for infants who may not have access to breastfeeding.

The primary purpose of HMO formula is to offer infants essential nutrients and bioactive components similar to those in breast milk. This includes providing support for immune defense, digestive health, and overall growth. The introduction of HMOs in infant formulas has revolutionized the infant nutrition market, offering a more scientific approach to supplementing breast milk for mothers who cannot breastfeed or who require additional support for their infants’ nutrition.

HMO formula milk typically comes in a range of variations to cater to specific infant needs. This includes:

Standard HMO formula: Aimed at healthy, full-term infants, providing all-around nutrition for growth and development.

Preterm and low birth weight HMO formula: Designed for premature or low birth weight infants, ensuring that their sensitive digestive systems receive the necessary support for optimal health.

Sensitive stomach HMO formula: Made for babies experiencing digestive discomforts like colic or reflux, this formula may contain additional components like probiotics or easier-to-digest proteins.

HMO formula with additional probiotics or nutrients: To support not just gut health but also immune development, these formulas combine HMOs with other beneficial ingredients such as probiotics, prebiotics, or DHA (docosahexaenoic acid).

The product is available in various forms such as powder, ready-to-feed liquid, and concentrated liquid, allowing parents to choose based on convenience and preference.

The market for HMO formula milk has experienced rapid growth due to several key factors. The growing awareness among parents of the critical role HMOs play in infant health has been a driving force. With increasing understanding of the benefits of HMOs in mimicking the bioactive components of breast milk, there is a rising demand for infant formulas that incorporate these oligosaccharides. As breastfeeding rates decline in some parts of the world, especially in urban areas, the demand for high-quality alternatives such as HMO formula milk has surged.

Market Opportunities: The emerging markets in Asia, Latin America, and the Middle East present significant growth opportunities for companies offering HMO-based formula milk. With rising disposable incomes and increased awareness of the importance of infant nutrition, these regions are expected to witness substantial demand for premium formula products. Innovations in production technologies, such as fermentation processes to create HMOs more efficiently, are also expected to make HMO-based formula more cost-effective, driving wider adoption across different demographics. Additionally, as more regulatory authorities approve the inclusion of HMOs in infant formula, companies have more opportunities to expand into new regions.

Market Risks: One of the major risks in the HMO formula market is the high production cost. The extraction and synthesis of HMOs remain an expensive and complex process, which can increase the price of the formula and limit its accessibility in price-sensitive markets. Regulatory challenges can also pose risks, as the approval of HMO inclusion in infant formula is still subject to different guidelines across regions. Furthermore, competition among major players in the market, including Abbott, Nestlé, Danone, and Mead Johnson, can limit market entry for smaller players, making it challenging for new companies to compete on price and innovation.

Market Concentration: The market is currently highly concentrated, with a few key players dominating the industry. Global giants like Abbott, Nestlé, Danone, and FrieslandCampina hold significant market share, primarily due to their established brand presence and distribution networks. This concentration of power limits opportunities for new entrants, although the growing consumer demand for HMO-based formula may attract smaller players looking to target niche segments of the market. However, as the market grows and diversifies, there may be room for more players to carve out a place.

Downstream Demand Trends: As consumer awareness about the benefits of HMO formula milk continues to rise, especially in developed markets, the demand for these formulas is expected to grow. Parents are increasingly looking for infant nutrition options that offer both convenience and nutritional superiority over traditional formulas. As breastfeeding rates are lower in some regions, particularly in developed countries, more parents are turning to HMO-based formulas to ensure their babies receive the best possible start in life. There is also a rising trend in seeking organic and clean-label formulas, which is likely to benefit the HMO formula segment as it is often marketed as a more natural and science-backed alternative to traditional formula milk.

Latest Technologies: The use of biotechnology in HMO production has been a major advancement in the field of infant nutrition. Companies are leveraging fermentation-based techniques to produce HMOs more efficiently and cost-effectively. These advances have the potential to reduce the cost of HMO formula milk, making it more accessible to a broader market. Additionally, the incorporation of other beneficial ingredients, such as prebiotics, probiotics, and DHA, alongside HMOs, is gaining traction as part of the latest innovations in the industry. These ingredients work synergistically to support the infant’s immune system, digestive health, and overall development.

This report aims to provide a comprehensive presentation of the global market for HMO Formula, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of HMO Formula by region & country, by Type, and by Application.

The HMO Formula market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HMO Formula.

MARKET SEGMENTATION

By Company

Abbott
Mead Johnson (Reckitt)
Nestlé
Danone
FrieslandCampina(Friso)
Yili Group

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Powder
Liquid

Segment by Application

Online Sales
Offline Sales

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of HMO Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of HMO Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of HMO Formula in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 HMO Formula Product Introduction

1.2 Global HMO Formula Market Size Forecast

1.2.1 Global HMO Formula Sales Value (2020-2031)

1.2.2 Global HMO Formula Sales Volume (2020-2031)

1.2.3 Global HMO Formula Sales Price (2020-2031)

1.3 HMO Formula Market Trends & Drivers

1.3.1 HMO Formula Industry Trends

1.3.2 HMO Formula Market Drivers & Opportunity

1.3.3 HMO Formula Market Challenges

1.3.4 HMO Formula Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global HMO Formula Players Revenue Ranking (2024)

2.2 Global HMO Formula Revenue by Company (2020-2025)

2.3 Global HMO Formula Players Sales Volume Ranking (2024)

2.4 Global HMO Formula Sales Volume by Company Players (2020-2025)

2.5 Global HMO Formula Average Price by Company (2020-2025)

2.6 Key Manufacturers HMO Formula Manufacturing Base and Headquarters

2.7 Key Manufacturers HMO Formula Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of HMO Formula

2.9 HMO Formula Market Competitive Analysis

2.9.1 HMO Formula Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by HMO Formula Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMO Formula as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Powder

3.1.2 Liquid

3.2 Global HMO Formula Sales Value by Type

3.2.1 Global HMO Formula Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global HMO Formula Sales Value, by Type (2020-2031)

3.2.3 Global HMO Formula Sales Value, by Type (%) (2020-2031)

3.3 Global HMO Formula Sales Volume by Type

3.3.1 Global HMO Formula Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global HMO Formula Sales Volume, by Type (2020-2031)

3.3.3 Global HMO Formula Sales Volume, by Type (%) (2020-2031)

3.4 Global HMO Formula Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Online Sales

4.1.2 Offline Sales

4.2 Global HMO Formula Sales Value by Application

4.2.1 Global HMO Formula Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global HMO Formula Sales Value, by Application (2020-2031)

4.2.3 Global HMO Formula Sales Value, by Application (%) (2020-2031)

4.3 Global HMO Formula Sales Volume by Application

4.3.1 Global HMO Formula Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global HMO Formula Sales Volume, by Application (2020-2031)

4.3.3 Global HMO Formula Sales Volume, by Application (%) (2020-2031)

4.4 Global HMO Formula Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global HMO Formula Sales Value by Region

5.1.1 Global HMO Formula Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global HMO Formula Sales Value by Region (2020-2025)

5.1.3 Global HMO Formula Sales Value by Region (2026-2031)

5.1.4 Global HMO Formula Sales Value by Region (%), (2020-2031)

5.2 Global HMO Formula Sales Volume by Region

5.2.1 Global HMO Formula Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global HMO Formula Sales Volume by Region (2020-2025)

5.2.3 Global HMO Formula Sales Volume by Region (2026-2031)

5.2.4 Global HMO Formula Sales Volume by Region (%), (2020-2031)

5.3 Global HMO Formula Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America HMO Formula Sales Value, 2020-2031

5.4.2 North America HMO Formula Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe HMO Formula Sales Value, 2020-2031

5.5.2 Europe HMO Formula Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific HMO Formula Sales Value, 2020-2031

5.6.2 Asia Pacific HMO Formula Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America HMO Formula Sales Value, 2020-2031

5.7.2 South America HMO Formula Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa HMO Formula Sales Value, 2020-2031

5.8.2 Middle East & Africa HMO Formula Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions HMO Formula Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions HMO Formula Sales Value and Sales Volume

6.2.1 Key Countries/Regions HMO Formula Sales Value, 2020-2031

6.2.2 Key Countries/Regions HMO Formula Sales Volume, 2020-2031

6.3 United States

6.3.1 United States HMO Formula Sales Value, 2020-2031

6.3.2 United States HMO Formula Sales Value by Type (%), 2024 VS 2031

6.3.3 United States HMO Formula Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe HMO Formula Sales Value, 2020-2031

6.4.2 Europe HMO Formula Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe HMO Formula Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China HMO Formula Sales Value, 2020-2031

6.5.2 China HMO Formula Sales Value by Type (%), 2024 VS 2031

6.5.3 China HMO Formula Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan HMO Formula Sales Value, 2020-2031

6.6.2 Japan HMO Formula Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan HMO Formula Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea HMO Formula Sales Value, 2020-2031

6.7.2 South Korea HMO Formula Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea HMO Formula Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia HMO Formula Sales Value, 2020-2031

6.8.2 Southeast Asia HMO Formula Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia HMO Formula Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India HMO Formula Sales Value, 2020-2031

6.9.2 India HMO Formula Sales Value by Type (%), 2024 VS 2031

6.9.3 India HMO Formula Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Abbott

7.1.1 Abbott Company Information

7.1.2 Abbott Introduction and Business Overview

7.1.3 Abbott HMO Formula Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Abbott HMO Formula Product Offerings

7.1.5 Abbott Recent Development

7.2 Mead Johnson (Reckitt)

7.2.1 Mead Johnson (Reckitt) Company Information

7.2.2 Mead Johnson (Reckitt) Introduction and Business Overview

7.2.3 Mead Johnson (Reckitt) HMO Formula Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Mead Johnson (Reckitt) HMO Formula Product Offerings

7.2.5 Mead Johnson (Reckitt) Recent Development

7.3 Nestlé

7.3.1 Nestlé Company Information

7.3.2 Nestlé Introduction and Business Overview

7.3.3 Nestlé HMO Formula Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Nestlé HMO Formula Product Offerings

7.3.5 Nestlé Recent Development

7.4 Danone

7.4.1 Danone Company Information

7.4.2 Danone Introduction and Business Overview

7.4.3 Danone HMO Formula Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Danone HMO Formula Product Offerings

7.4.5 Danone Recent Development

7.5 FrieslandCampina(Friso)

7.5.1 FrieslandCampina(Friso) Company Information

7.5.2 FrieslandCampina(Friso) Introduction and Business Overview

7.5.3 FrieslandCampina(Friso) HMO Formula Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 FrieslandCampina(Friso) HMO Formula Product Offerings

7.5.5 FrieslandCampina(Friso) Recent Development

7.6 Yili Group

7.6.1 Yili Group Company Information

7.6.2 Yili Group Introduction and Business Overview

7.6.3 Yili Group HMO Formula Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Yili Group HMO Formula Product Offerings

7.6.5 Yili Group Recent Development

8 Industry Chain Analysis

8.1 HMO Formula Industrial Chain

8.2 HMO Formula Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 HMO Formula Sales Model

8.5.2 Sales Channel

8.5.3 HMO Formula Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. HMO Formula Market Trends

Table 2. HMO Formula Market Drivers & Opportunity

Table 3. HMO Formula Market Challenges

Table 4. HMO Formula Market Restraints

Table 5. Global HMO Formula Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global HMO Formula Revenue Market Share by Company (2020-2025)

Table 7. Global HMO Formula Sales Volume by Company (2020-2025) & (K Tons)

Table 8. Global HMO Formula Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market HMO Formula Price by Company (2020-2025) & (US$/Ton)

Table 10. Key Manufacturers HMO Formula Manufacturing Base and Headquarters

Table 11. Key Manufacturers HMO Formula Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of HMO Formula

Table 13. Global HMO Formula Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMO Formula as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global HMO Formula Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global HMO Formula Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global HMO Formula Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global HMO Formula Sales Market Share in Value by Type (2020-2025)

Table 20. Global HMO Formula Sales Market Share in Value by Type (2026-2031)

Table 21. Global HMO Formula Sales Volume by Type: 2020 VS 2024 VS 2031 (K Tons)

Table 22. Global HMO Formula Sales Volume by Type (2020-2025) & (K Tons)

Table 23. Global HMO Formula Sales Volume by Type (2026-2031) & (K Tons)

Table 24. Global HMO Formula Sales Volume Market Share by Type (2020-2025)

Table 25. Global HMO Formula Sales Volume Market Share by Type (2026-2031)

Table 26. Global HMO Formula Price by Type (2020-2025) & (US$/Ton)

Table 27. Global HMO Formula Price by Type (2026-2031) & (US$/Ton)

Table 28. Global HMO Formula Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global HMO Formula Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global HMO Formula Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global HMO Formula Sales Market Share in Value by Application (2020-2025)

Table 32. Global HMO Formula Sales Market Share in Value by Application (2026-2031)

Table 33. Global HMO Formula Sales Volume by Application: 2020 VS 2024 VS 2031 (K Tons)

Table 34. Global HMO Formula Sales Volume by Application (2020-2025) & (K Tons)

Table 35. Global HMO Formula Sales Volume by Application (2026-2031) & (K Tons)

Table 36. Global HMO Formula Sales Volume Market Share by Application (2020-2025)

Table 37. Global HMO Formula Sales Volume Market Share by Application (2026-2031)

Table 38. Global HMO Formula Price by Application (2020-2025) & (US$/Ton)

Table 39. Global HMO Formula Price by Application (2026-2031) & (US$/Ton)

Table 40. Global HMO Formula Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global HMO Formula Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global HMO Formula Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global HMO Formula Sales Value by Region (2020-2025) & (%)

Table 44. Global HMO Formula Sales Value by Region (2026-2031) & (%)

Table 45. Global HMO Formula Sales Volume by Region (K Tons): 2020 VS 2024 VS 2031

Table 46. Global HMO Formula Sales Volume by Region (2020-2025) & (K Tons)

Table 47. Global HMO Formula Sales Volume by Region (2026-2031) & (K Tons)

Table 48. Global HMO Formula Sales Volume by Region (2020-2025) & (%)

Table 49. Global HMO Formula Sales Volume by Region (2026-2031) & (%)

Table 50. Global HMO Formula Average Price by Region (2020-2025) & (US$/Ton)

Table 51. Global HMO Formula Average Price by Region (2026-2031) & (US$/Ton)

Table 52. Key Countries/Regions HMO Formula Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions HMO Formula Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions HMO Formula Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions HMO Formula Sales Volume, (2020-2025) & (K Tons)

Table 56. Key Countries/Regions HMO Formula Sales Volume, (2026-2031) & (K Tons)

Table 57. Abbott Company Information

Table 58. Abbott Introduction and Business Overview

Table 59. Abbott HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 60. Abbott HMO Formula Product Offerings

Table 61. Abbott Recent Development

Table 62. Mead Johnson (Reckitt) Company Information

Table 63. Mead Johnson (Reckitt) Introduction and Business Overview

Table 64. Mead Johnson (Reckitt) HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 65. Mead Johnson (Reckitt) HMO Formula Product Offerings

Table 66. Mead Johnson (Reckitt) Recent Development

Table 67. Nestlé Company Information

Table 68. Nestlé Introduction and Business Overview

Table 69. Nestlé HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 70. Nestlé HMO Formula Product Offerings

Table 71. Nestlé Recent Development

Table 72. Danone Company Information

Table 73. Danone Introduction and Business Overview

Table 74. Danone HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Danone HMO Formula Product Offerings

Table 76. Danone Recent Development

Table 77. FrieslandCampina(Friso) Company Information

Table 78. FrieslandCampina(Friso) Introduction and Business Overview

Table 79. FrieslandCampina(Friso) HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 80. FrieslandCampina(Friso) HMO Formula Product Offerings

Table 81. FrieslandCampina(Friso) Recent Development

Table 82. Yili Group Company Information

Table 83. Yili Group Introduction and Business Overview

Table 84. Yili Group HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 85. Yili Group HMO Formula Product Offerings

Table 86. Yili Group Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. HMO Formula Downstream Customers

Table 90. HMO Formula Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. HMO Formula Product Picture

Figure 2. Global HMO Formula Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global HMO Formula Sales Value (2020-2031) & (US$ Million)

Figure 4. Global HMO Formula Sales Volume (2020-2031) & (K Tons)

Figure 5. Global HMO Formula Sales Price (2020-2031) & (US$/Ton)

Figure 6. HMO Formula Report Years Considered

Figure 7. Global HMO Formula Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global HMO Formula Players Sales Volume Ranking (2024) & (K Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by HMO Formula Revenue in 2024

Figure 10. HMO Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Powder Picture

Figure 12. Liquid Picture

Figure 13. Global HMO Formula Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global HMO Formula Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global HMO Formula Sales Volume by Type (2020 VS 2024 VS 2031) & (K Tons)

Figure 16. Global HMO Formula Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global HMO Formula Price by Type (2020-2031) & (US$/Ton)

Figure 18. Product Picture of Online Sales

Figure 19. Product Picture of Offline Sales

Figure 20. Global HMO Formula Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global HMO Formula Sales Value Market Share by Application, 2024 & 2031

Figure 22. Global HMO Formula Sales Volume by Application (2020 VS 2024 VS 2031) & (K Tons)

Figure 23. Global HMO Formula Sales Volume Market Share by Application, 2024 & 2031

Figure 24. Global HMO Formula Price by Application (2020-2031) & (US$/Ton)

Figure 25. North America HMO Formula Sales Value (2020-2031) & (US$ Million)

Figure 26. North America HMO Formula Sales Value by Country (%), 2024 VS 2031

Figure 27. Europe HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 28. Europe HMO Formula Sales Value by Country (%), 2024 VS 2031

Figure 29. Asia Pacific HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 30. Asia Pacific HMO Formula Sales Value by Region (%), 2024 VS 2031

Figure 31. South America HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 32. South America HMO Formula Sales Value by Country (%), 2024 VS 2031

Figure 33. Middle East & Africa HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 34. Middle East & Africa HMO Formula Sales Value by Country (%), 2024 VS 2031

Figure 35. Key Countries/Regions HMO Formula Sales Value (%), (2020-2031)

Figure 36. Key Countries/Regions HMO Formula Sales Volume (%), (2020-2031)

Figure 37. United States HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 38. United States HMO Formula Sales Value by Type (%), 2024 VS 2031

Figure 39. United States HMO Formula Sales Value by Application (%), 2024 VS 2031

Figure 40. Europe HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 41. Europe HMO Formula Sales Value by Type (%), 2024 VS 2031

Figure 42. Europe HMO Formula Sales Value by Application (%), 2024 VS 2031

Figure 43. China HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 44. China HMO Formula Sales Value by Type (%), 2024 VS 2031

Figure 45. China HMO Formula Sales Value by Application (%), 2024 VS 2031

Figure 46. Japan HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 47. Japan HMO Formula Sales Value by Type (%), 2024 VS 2031

Figure 48. Japan HMO Formula Sales Value by Application (%), 2024 VS 2031

Figure 49. South Korea HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 50. South Korea HMO Formula Sales Value by Type (%), 2024 VS 2031

Figure 51. South Korea HMO Formula Sales Value by Application (%), 2024 VS 2031

Figure 52. Southeast Asia HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 53. Southeast Asia HMO Formula Sales Value by Type (%), 2024 VS 2031

Figure 54. Southeast Asia HMO Formula Sales Value by Application (%), 2024 VS 2031

Figure 55. India HMO Formula Sales Value, (2020-2031) & (US$ Million)

Figure 56. India HMO Formula Sales Value by Type (%), 2024 VS 2031

Figure 57. India HMO Formula Sales Value by Application (%), 2024 VS 2031

Figure 58. HMO Formula Industrial Chain

Figure 59. HMO Formula Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of HMO Formula in 2025? zhanKai

The global market size of HMO Formula in 2025 was 4200 Million USD.

Which companies rank high in the global HMO Formula market? shouQi

What is the annual compound growth rate of the global HMO Formula market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of HMO Formula in 2031? shouQi

Related Reports

Global HMO Formula Market Outlook, In‑Depth Analysis & Forecast to 2032
The global HMO Formula market is projected to grow from US$ 4200 million in 2025 to US$ 8633 million by 2032, at a CAGR of 11.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 136
USD 4900.00
(Single User License)
Global HMO Formula Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global HMO Formula market size was US$ 4200 million in 2025 and is forecast to reach a readjusted size of US$ 8633 million by 2032 with a CAGR of 11.0% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 80
USD 4250.00
(Single User License)
HMO Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for HMO Formula was estimated to be worth US$ 4200 million in 2025 and is projected to reach US$ 8633 million, growing at a CAGR of 11.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 107
USD 3950.00
(Single User License)
Global HMO Formula Market Research Report 2026
The global HMO Formula market was valued at US$ 4200 million in 2025 and is anticipated to reach US$ 8633 million by 2032, at a CAGR of 11.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 110
USD 2900.00
(Single User License)
Global HMO Formula Market Outlook, In‑Depth Analysis & Forecast to 2031
The global HMO Formula market is projected to grow from US$ 3900 million in 2024 to US$ 7856 million by 2031, at a CAGR of 11.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-02
Pages: 146
USD 4900.00
(Single User License)
Global HMO Formula Market Research Report 2025
The global market for HMO Formula was valued at US$ 3900 million in the year 2024 and is projected to reach a revised size of US$ 7856 million by 2031, growing at a CAGR of 11.0% during the forecast period.
Published Date: 2025-03-10
Pages: 86
USD 2900.00
(Single User License)
Global HMO Formula Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global HMO Formula market size was US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 77
USD 4250.00
(Single User License)
Global HMO Formula Market Research Report 2024
The global HMO Formula market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 93
USD 2900.00
(Single User License)
HMO Formula - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for HMO Formula was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 124
USD 3950.00
(Single User License)

Global HMO Formula Market Outlook, In‑Depth Analysis & Forecast to 2032
The global HMO Formula market is projected to grow from US$ 4200 million in 2025 to US$ 8633 million by 2032, at a CAGR of 11.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 136
USD 4900.00 (Single User License)
Global HMO Formula Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global HMO Formula market size was US$ 4200 million in 2025 and is forecast to reach a readjusted size of US$ 8633 million by 2032 with a CAGR of 11.0% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 80
USD 4250.00 (Single User License)
HMO Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for HMO Formula was estimated to be worth US$ 4200 million in 2025 and is projected to reach US$ 8633 million, growing at a CAGR of 11.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 107
USD 3950.00 (Single User License)
Global HMO Formula Market Research Report 2026
The global HMO Formula market was valued at US$ 4200 million in 2025 and is anticipated to reach US$ 8633 million by 2032, at a CAGR of 11.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 110
USD 2900.00 (Single User License)
Global HMO Formula Market Outlook, In‑Depth Analysis & Forecast to 2031
The global HMO Formula market is projected to grow from US$ 3900 million in 2024 to US$ 7856 million by 2031, at a CAGR of 11.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-02
Pages: 146
USD 4900.00 (Single User License)
Global HMO Formula Market Research Report 2025
The global market for HMO Formula was valued at US$ 3900 million in the year 2024 and is projected to reach a revised size of US$ 7856 million by 2031, growing at a CAGR of 11.0% during the forecast period.
Published: 2025-03-10
Pages: 86
USD 2900.00 (Single User License)
Global HMO Formula Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global HMO Formula market size was US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 77
USD 4250.00 (Single User License)
Global HMO Formula Market Research Report 2024
The global HMO Formula market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 93
USD 2900.00 (Single User License)
HMO Formula - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for HMO Formula was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 124
USD 3950.00 (Single User License)